The stock has a 36-month beta value of -1.64. Opinions on the stock are mixed, with 1 analysts rating it as a “buy”, 1 as “overweight”, 0 as “hold”, and 0 as “sell”.
The public float for GRI is 2.35M, and at present, short sellers hold a 2.58% of that float. On July 04, 2025, the average trading volume of GRI was 293.45K shares.
GRI stock’s latest price update
The stock of GRI Bio Inc (NASDAQ: GRI) has decreased by -0.69% when compared to last closing price of $1.45.Despite this, the company has seen a gain of 12.50% in its stock price over the last five trading days. globenewswire.com reported 2025-07-01 that Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, limited patient compliance and no impact on survival
GRI’s Market Performance
GRI Bio Inc (GRI) has seen a 12.50% rise in stock performance for the week, with a 6.67% gain in the past month and a -13.77% plunge in the past quarter. The volatility ratio for the week is 7.27%, and the volatility levels for the past 30 days are at 8.00% for GRI. The simple moving average for the last 20 days is 6.59% for GRI’s stock, with a simple moving average of -80.86% for the last 200 days.
Analysts’ Opinion of GRI
Many brokerage firms have already submitted their reports for GRI stocks, with H.C. Wainwright repeating the rating for GRI by listing it as a “Buy”. The predicted price for GRI in the upcoming period, according to H.C. Wainwright is $10 based on the research report published on December 09, 2024 of the previous year 2024.
GRI Trading at -3.04% from the 50-Day Moving Average
After a stumble in the market that brought GRI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -96.70% of loss for the given period.
Volatility was left at 8.00%, however, over the last 30 days, the volatility rate increased by 7.27%, as shares sank -0.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.69% lower at present.
During the last 5 trading sessions, GRI rose by +12.50%, which changed the moving average for the period of 200-days by -83.14% in comparison to the 20-day moving average, which settled at $1.3510. In addition, GRI Bio Inc saw -95.54% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
N/A, the N/A of GRI Bio Inc, N/A N/A shares at N/A during a trade that took place back on N/A, which means that N/A is holding N/A shares at N/A based on the most recent closing price.
Stock Fundamentals for GRI
The total capital return value is set at -2.01%. Equity return is now at value -468.00%, with -217.11% for asset returns.
Based on GRI Bio Inc (GRI), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -72.36.
Currently, EBITDA for the company is -8.23 million with net debt to EBITDA at 0.6. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.41.
Conclusion
To sum up, GRI Bio Inc (GRI) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
